Trump Admin Live updates: ‘Legal details’ of Jatar Jumbo Jet’s gift that is “resolved”, says the White House.

To carry out the president’s executive order aimed at reducing the prices of prescription medications, the White House said it will open negotiations with the pharmaceutical companies at some point in next month and will eventually follow the formal regulations if they are not advanced.

The White House awaits at least some voluntary offers of companies, authorities said, because a large component of this plan is to help companies increase their prices in other countries.

“There will still be a lot of money for research and development purposes, but only the United States will not have that cost,” said a White House official in a call with journalists on Monday.

Essentially, according to the president’s opinion that the United States often has the weight of other countries and obtains the short end of the stick, this drug price policy will try to redistribute some of the costs of prescription drugs from the United States to other countries.

The United States represents less than 5% of the world’s population, but approximately three quarters of world pharmaceutical profits, authorities said.

At the national level, the White House will lead the Secretary of Health and Human Services Robert F. Kennedy Jr. to “establish clear objectives for price reductions in all markets in the United States”, not only in Medicare programs financed by the Government, in the next 30 days.

“If adequate progress is not made for these price reduction objectives, the Secretary of Health and Human Services will impose the most favored nation prices through regulations,” said a White House official.

The administration was scarce on the details about which medications will be prioritized, but said that it will analyze the most expensive medications and that it will probably include weight loss medications.

-ABC New News’ You and Countel Haslett